Patient Monitoring Devices are used to observe, measure, and record vital signs in patients. A Capnograph is a device that continuously analyses and records the level of carbon dioxide [CO2] in respiratory gases. GlobalData uses proprietary data and analytics to provide a comprehensive report on the capnographs devices market, including market shares of different players within the US. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the capnographs market in the US was Medtronic followed by Nihon Kohden, Becton Dickinson and Co, Koninklijke Philips, Dragerwerk, Masimo and Nonin Medical.
Capnographs are monitors which measure the exhaled carbon dioxide by measuring the absorption of infrared light. Capnographs comes with monitors and sensors. Both Bedside Capnographs and Portable Capnographs are included. Bedside Capnographs are stand-alone devices that incorporate side stream technology for applications with both intubated and non-intubated patients. Portable Capnograph is a full-featured, highly portable unit in a choice of configurations, delivering capnography.
The value of the capnographs devices market within the US was expected to be over $200m in 2023.
For the latest complete market share analysis of capnographs device market in the US, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
